← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 29, 2018Last known activity
Feb 28, 2024
Timeline
2010s
- Nov 1, 2016
Viracta Therapeutics, Inc.— Founded
2020s
- Feb 25, 2021
Sunesis Pharmaceuticals— Acquired
Drugs by trial phase (10 distinct, 20 trials)
Phase 3 (0 own, 2 via acquisition)
Phase 2 (3 own, 3 via acquisition)
Phase 1 (0 own, 2 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (8)
- NCT06302140OfficialPhase 1Feb 28, 2024
- NCT06302140Lead sponsorPhase 1Feb 28, 2024
- NCT05166577Study directorPhase 1/Phase 2Oct 7, 2021
- NCT05166577Lead sponsorPhase 1/Phase 2Oct 7, 2021
- NCT05011058Study directorPhase 2Aug 31, 2021
- NCT05011058Lead sponsorPhase 2Aug 31, 2021
- NCT03397706Lead sponsorPhase 1/Phase 2Mar 29, 2018
- NCT03397706Study directorPhase 1/Phase 2Mar 29, 2018
Details
- Founded
- San Diego, CA, US Nov 1, 2016
- Last known activity
- Feb 28, 2024